Some argue that higher fees reflect the expertise and demand for specialized services. They contend that patients who can afford it should bear the cost to ensure quality care remains available. However, this logic fails to address the broader public health implications when essential medical services become inaccessible due to financial barriers.

The risk lies in the potential long-term health consequences of delaying necessary dermatological treatment.

Private healthcare providers may benefit from higher fees but at the expense of public health and equity.

As costs continue to rise, expect a growing divide between those who can access quality dermatological care and those who cannot. The trend towards privatization may further erode public trust in healthcare systems, pushing more Australians into precarious financial situations while seeking necessary medical attention.

This issue will likely polarize public opinion sharply. Those with the means to pay for private services will support the status quo, while others will demand urgent reforms to make essential care accessible and affordable for all.